Table 3 Reproductive system abnormalities in adolescent female epilepsy patients before and after VPA initial treatment (n = 40)
From: The safety of valproic acid treatment in children with epilepsy: a retrospective real-world research
Symptom/examination | VPA initial treatment | P value | |
|---|---|---|---|
Before | After | ||
Menstrual disorder or dysmenorrhea | 1 (5.0) | 5 (20.0) | 0.205 |
Ovarian cystic mass | 2 (9.5) | 4 (15.4) | 0.678 |